M4Q(R2); The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality; Draft Guidance
Details
The document's own metadata, straight from the source system.
- Title
- M4Q(R2); The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality; Draft Guidance
- Posted
- Jan 21, 2026
- Comment period
- Jan 21, 2026 – Mar 24, 2026
- Topics
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Choose up to five.
| Organization | Transition period |
|---|
3 organization-typed comments could not be identified.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Mar 5, 2026Comment from Michael StraussOtherIndividual
A pharmaceutical consultant notes that the proposed M4Q(R2) structure omits the compatibility of installation materials (like lines and tubing) which were present in the old eCTD format. The commenter requests that the FDA clarify how this change will affect IND filings and provide a timeline for updating the eCTD structure.
Read comment → - Jan 23, 2026Comment from Harun SinhaOtherIndividualRead comment →